Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2005
12/14/2005CN1231262C Mimetic peptides for epitope of apolipoprotein B-100, concatemer and modified peptides, and vaccine composition comprising the same
12/13/2005US6974864 Viral mucleotide sequences for use in the diagnosis and treatment of viral diseases
12/13/2005US6974861 Conjestive heart failure; polypeptide
12/13/2005US6974686 Recombinant tryptophan mutants of influenza
12/13/2005US6974681 Cell culture performance with vanadate
12/13/2005CA2234073C Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins
12/13/2005CA2001328C Borrelia antigen
12/10/2005CA2507847A1 Prostaglandin reductase
12/10/2005CA2507738A1 Modulation of peroxisome proliferator-activated receptors
12/08/2005WO2005116650A2 High throughput discovery of materials through vapor phase synthesis
12/08/2005WO2005116628A1 Single-pass compound purification and analysis
12/08/2005WO2005116266A2 Methods of amplifying infectious proteins
12/08/2005WO2005116237A2 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination
12/08/2005WO2005116236A2 Methods for treating cancer using anti-wnt2 monoclonal antibodies and sirna
12/08/2005WO2005116235A2 Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment
12/08/2005WO2005116234A2 Detection and quantification of intracellular pathogens
12/08/2005WO2005116233A2 Composition and method of cancer treatment
12/08/2005WO2005116230A2 Golgi apparatus regenerated in vitro method for production and use thereof
12/08/2005WO2005116216A1 Oral vaccine against protozoiasis using genetically modified plant
12/08/2005WO2005116200A2 Nucleic acids and polypeptides involved in the production of cryptophycin
12/08/2005WO2005116080A1 Antibody specific for alkylphenol and use thereof
12/08/2005WO2005116079A1 Antibody capable of recognizing ligand of allylhydrocarbon receptor and use thereof
12/08/2005WO2005116059A1 Method of producing highly pure teicoplanin
12/08/2005WO2005115433A2 Methods for cyclizing synthetic polymers
12/08/2005WO2005100586A3 Method for construction and use of kluyveromyces lactis promoter variants in k.lactis that substantially lack e. coli transcriptional capability
12/08/2005WO2005093069A3 Production of mersacidin and its variants in sigh and/or mrsa negative bacillus host cells
12/08/2005WO2005075448A3 A method for manufacturing optically pure coumaryl amino acids salts and the coumaryl amino acid salts thus obtained
12/08/2005WO2005014779A9 Cyclodextrin affinity purification
12/08/2005WO2005011580A3 Compositions and methods for herpes simplex prophylaxis and treatment
12/08/2005WO2002066494A3 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
12/08/2005US20050273884 PUFA polyketide synthase systems and uses thereof
12/08/2005US20050273883 Pufa polyketide synthase systems and uses thereof
12/08/2005US20050273627 Biometrics in issuance of government documents
12/08/2005US20050273621 Multistate collaboration between departments of motor vehicles
12/08/2005US20050272924 Invention provides a DNA molecule capable of expressing a heterologous polypeptide under cold shock conditions, where the DNA molecule is preferably a self-replicating expression vector
12/08/2005US20050272918 Method of treating allergy using antibody against human interleukin-5 receptor alpha chain
12/08/2005US20050272916 Method of modulating the activity of functional immune molecules
12/08/2005US20050272864 Method and device for improving protein stability and solubility
12/08/2005US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use
12/08/2005US20050272131 Methods to make and use antibodies of improved cross-reactivity
12/08/2005US20050272129 Filamentous fungus belonging to a species Colletotrichum gloeosporioides or Aspergillus niger; improved biomass production in solid and liquid culture; for biocontrol
12/08/2005US20050272128 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
12/08/2005US20050272127 Antibody against an angiogenesis-inhibiting peptide homologous to human ChM1L chondromodulin-I (ChM-I); hybridomas; diagnostic kits; controlling angiogenesis
12/08/2005US20050272126 Testis-specific differentiation-regulatory factor
12/08/2005US20050272124 Polypeptide production in animal cell culture
12/08/2005US20050272121 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for structure determination
12/08/2005US20050272120 Compositions and methods for the diagnosis and treatment of tumor
12/08/2005US20050272117 Method
12/08/2005US20050272116 Polymer substrate for recombinant protein purification and environmental remediation
12/08/2005US20050272094 Purified antigen for Alzheimer's disease and methods of obtaining and using same
12/08/2005US20050272093 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
12/08/2005US20050272091 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection
12/08/2005US20050272058 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/08/2005US20050272041 isolated polynucleotide encoding Enzymatic proteins for use in food processing, paper making and recycling
12/08/2005US20050271688 Modified vaccinia ankara virus variant
12/08/2005US20050271681 Isolated FrpB nucleic acid molecule and vaccine
12/08/2005US20050271679 Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens
12/08/2005US20050271678 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates
12/08/2005US20050271664 Antibodies for inhibiting blood coagulation and methods of use thereof
12/08/2005US20050271659 Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
12/08/2005US20050271655 Nogo receptor antagonists
12/08/2005US20050271654 Antibody purification
12/08/2005US20050271647 Chimeric pro-caspases and methods of using same
12/08/2005US20050271618 Methods of reducing aggregation of IL-1ra
12/08/2005DE102004022435A1 Verfahren zur Herstellung löslicher MHC-Proteine Process for the preparation of soluble MHC proteins
12/08/2005CA2567952A1 Oral anti-protozoiasis vaccines based on transgenic plants
12/08/2005CA2567814A1 Antibodies as t cell receptor mimics, methods of production and uses thereof
12/08/2005CA2567749A1 Methods for evaluating ribonucleotide sequences
12/08/2005CA2567624A1 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination
12/08/2005CA2566498A1 Methods for treating cancer using anti-wnt2 monoclonal antibodies and sirna
12/08/2005CA2565794A1 Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment
12/08/2005CA2562241A1 Detection and quantification of intracellular pathogens
12/08/2005CA2558871A1 Composition and method of cancer treatment
12/07/2005EP1602720A1 Process for producing foreign protein in escherichia coli
12/07/2005EP1602719A1 Control of transglutaminase catalyzed protein modification by selective irreversible transglutaminase inhibitors
12/07/2005EP1602669A1 Antibody against tumor specific antigen as target
12/07/2005EP1602668A1 Monoclonal antibodies specific to VEGF receptors and uses thereof
12/07/2005EP1602666A1 Novel protein and its dna
12/07/2005EP1601947A2 Diagnostic test for west nile virus
12/07/2005EP1601779A2 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use
12/07/2005EP1601761A1 Improved protein secretion in eukaryotic cells
12/07/2005EP1601689A2 Purification process for bacterial cytolysin
12/07/2005EP1601450A2 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells
12/07/2005EP1601373A2 Intracellular delivery of small molecules proteins and nucleic acids
12/07/2005EP1601332A2 Hydrolases, nucleic acids encoding them and mehods for making and using them
12/07/2005EP1601327A2 Stabilized hbc chimer particles as therapeutic vaccine for chronic hepatitis
12/07/2005EP1423409A4 Gastrokines and derived peptides including inhibitors
12/07/2005EP1266006B1 Production of recombinant muteins of blood clotting factor viii in human cell lines
12/07/2005EP1230551B1 Methods to identify compounds that modulate neuronal activity
12/07/2005EP1222298B1 Vectors and methods for recombinant protein expression
12/07/2005EP1181356B1 Phosphine stabilizers for oxidoreductase enzymes
12/07/2005EP1141310B1 Production of proteins in gram-positive microorganisms
12/07/2005EP1004673B1 Process for producing foreign proteins
12/07/2005EP0873354B1 Novel amp activated protein kinase
12/07/2005EP0738328B1 Composition containing nucleic acids, preparation and uses
12/07/2005EP0697893B1 Neural thread protein gene expression and detection of alzheimer's disease
12/07/2005CN1705880A Methods for producing secreted polypeptides having L-asparaginase activity
12/07/2005CN1705749A Use of aminoglycoside resistance gene
12/07/2005CN1230546C Transformation system in field of flamentrous fungel hosts in chrysosporium
12/07/2005CN1230543C Production of proteins
1 ... 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 ... 1125